{"ticker": {"uuid": "138f4895-1bbe-4931-b6cf-29c8363ba93b", "symbol": "BMRA", "name": "Biomerica Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "BMRA - Biomerica Inc Short Interest", "summary": "This article provides a detailed financial overview and short interest data for Biomerica Inc. (BMRA). It includes key metrics such as market capitalization, sales, earnings per share, profit margins, and various performance indicators. The data also highlights the short interest", "url": "https://finviz.com/stock?t=BMRA&ty=si&p=d", "source_name": "Finviz", "published_at": "2026-07-06T00:10:55", "published_display": "06 Jul 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BMRA - Biomerica Inc Earnings", "summary": "This page provides an overview of Biomerica Inc.'s (BMRA) financial performance and key metrics. It includes details such as market capitalization, sales, income, EPS, insider ownership, institutional ownership, profitability ratios, and stock performance data. The company's stoc", "url": "https://finviz.com/stock?t=BMRA&ty=ea&p=d", "source_name": "Finviz", "published_at": "2026-07-04T23:39:50", "published_display": "04 Jul 2026 23:39", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Biomerica, Inc. \u2013 NASDAQ:BMRA", "summary": "The article focuses on the enterprise value to EBITDA forward for Biomerica, Inc. (NASDAQ: BMRA). It appears to be a financial data page from TradingView, displaying stock information and financial metrics for the company. The content also mentions the data sources and copyright ", "url": "https://www.tradingview.com/symbols/NASDAQ-BMRA/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T13:40:04", "published_display": "28 Jun 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Biomerica, Inc. \u2013 NASDAQ:BMRA", "summary": "This article provides financial data for Biomerica, Inc. (NASDAQ: BMRA), focusing on its forward price-to-sales ratio. It indicates that the market was closed with no trades at the time of reporting. The content is primarily a data page from TradingView, offering financial and ma", "url": "https://www.tradingview.com/symbols/NASDAQ-BMRA/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T09:11:26", "published_display": "26 Jun 2026 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc (BMRA) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of Biomerica Inc (BMRA), stating its current valuation score is 7.63, ranking 142 out of 203 in its industry. It highlights the company's current P/E ratio at -1.08, noting it is significantly below its recent high and above its recent l", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bmra/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-24T19:11:26", "published_display": "24 Jun 2026 19:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc (BMRA) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Biomerica Inc (BMRA) currently has a financial score of 6.12, ranking 174 out of 204 in the Healthcare Equipment & Supplies industry, indicating robust financial status but low operating efficiency. Its latest quarterly revenue saw an 11.80% year-over-year decrease to $987.00K, a", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bmra/financial-health", "source_name": "TradingKey", "published_at": "2026-06-23T07:11:43", "published_display": "23 Jun 2026 07:11", "sentiment": "negative", "sentiment_pct": 37, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans - moomoo", "summary": "This article states that Biomerica has filed an S-8 initial registration statement. This statement is for securities intended to be offered to employees through employee benefit plans. The filing was made public via moomoo.", "url": "https://www.moomoo.com/news/notice/306568807/biomerica-s-8-initial-registration-statement-for-securities-to-be", "source_name": "Moomoo", "published_at": "2026-06-22T07:40:00", "published_display": "22 Jun 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc (BMRA) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "The article provides an earnings forecast for Biomerica Inc (BMRA), noting that no earnings forecast score is currently available for the company. It indicates that the Healthcare Equipment & Supplies industry average score is 7.78. The page also displays current stock informatio", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bmra/earnings", "source_name": "TradingKey", "published_at": "2026-06-19T07:38:54", "published_display": "19 Jun 2026 07:38", "sentiment": "negative", "sentiment_pct": 41, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc (BMRA) Institutional Confidence", "summary": "This article from TradingKey focuses on the institutional confidence score for Biomerica Inc (BMRA), which stands at 3.00, unchanged as of June 18, 2026. It details the shareholdings and activity of several key individual and institutional shareholders, highlighting changes in th", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bmra/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T16:40:31", "published_display": "18 Jun 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc (BMRA) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Biomerica Inc.'s (BMRA) dividend history and stock split events. It indicates that the company has distributed no dividends in the past five years and notes a merger-type stock split event scheduled for April 16, 2025, with an 8-for-1 ratio. T", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bmra/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T16:38:54", "published_display": "17 Jun 2026 16:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc (BMRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Biomerica Inc (BMRA), detailing its current price momentum score as 4.88, trading between a resistance level of $2.34 and a support level of $1.75. The analysis includes various technical indicators like MACD, RSI, and moving averages", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bmra/technical", "source_name": "TradingKey", "published_at": "2026-06-17T16:11:18", "published_display": "17 Jun 2026 16:11", "sentiment": "negative", "sentiment_pct": 12, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc (BMRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for Biomerica Inc (BMRA), categorizing its revenue by business segment and geographical region. As of FY2026Q2, Clinical Lab and OTC segments are the largest contributors, while the United States and Asia lead in regional revenue", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bmra/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T15:40:19", "published_display": "17 Jun 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc (BMRA) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Biomerica Inc (BMRA), outlining both individual major shareholders and institutional holdings. It provides a breakdown of proportional ownership for key individuals like Zackary S. Irani, Allen Barbieri, and Gary Lu, as well as sh", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bmra/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T15:40:19", "published_display": "17 Jun 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biomerica (BMRA) Q1 2026 Earnings: Narrowing Loss Amid Ongoing Operational Challenges - Negative Surprise Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQY1pnWi1oMXFlRTBCeC0zY0pmMy1QY1V1Qjl5MXcxQ3FSSnV4S2NxZEVkMXpmTkpGREExSmU5ZUM4NVB3U05Balk5ZHFuUkRGSXllUndtNjgxM3VYV1dOM3NDR0RfSFBPYmtsbUhVNFhsUldhRVJZWTJCSkhDNHpJTUtZUU9XS0phTmVycS14ZlZxM2RQTWFlT1hlMVJ2YUtxNDM2NFZMQUk2Nkh5Y2RfRHdqQnE3YWNLSVJoMlpYVDZiLVhLdExPSnRSaEY?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica to Sell 6% Diagnosis Stake for $500,000; Issues 8% Note Pending Transfer", "summary": "Biomerica has agreed to sell a 6% stake in Diagnosis for $500,000 to affiliates of CEO Zackary Irani. Pending Polish approvals, Biomerica issued a secured 12-month note at 8% to hold the funds, which will be forgiven upon closing, except for 60 days of interest. The transaction i", "url": "https://www.tradingview.com/news/tradingview:3197901bbd14e:0-biomerica-to-sell-6-diagnosis-stake-for-500-000-issues-8-note-pending-transfer/", "source_name": "TradingView", "published_at": "2026-06-04T21:10:19", "published_display": "04 Jun 2026 21:10", "sentiment": "positive", "sentiment_pct": 63, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica (BMRA) sells 6% Diagnosis S.A. stake to CEO-affiliated buyers", "summary": "Biomerica, Inc. has entered into an agreement to sell 78,750 shares of Diagnosis S.A., roughly 6% of its outstanding shares, to buyers affiliated with its CEO, Zackary Irani, for $500,000. The transaction involves a secured promissory term note bearing 8% annual interest, maturin", "url": "https://www.stocktitan.net/sec-filings/BMRA/8-k-biomerica-inc-reports-material-event-2a02a17fb1d7.html", "source_name": "Stock Titan", "published_at": "2026-06-04T21:10:19", "published_display": "04 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BMRA - Biomerica Inc Stock Price and Quote", "summary": "This article provides a detailed financial overview and recent news for Biomerica Inc. (BMRA), including its stock price, market capitalization, key financial ratios, and performance metrics. It also lists recent company announcements, such as new product approvals, clinical stud", "url": "https://finviz.com/stock?t=BMRA", "source_name": "Finviz", "published_at": "2026-05-30T21:40:06", "published_display": "30 May 2026 21:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica secures USD 1.75M contract for IVD diagnostic development", "summary": "Biomerica, Inc. has secured a Master Services Agreement with a confidential life sciences company for over $1.75 million to develop proprietary in vitro diagnostic (IVD) assays. This CDMO engagement leverages Biomerica's existing ELISA-based assay development expertise and infras", "url": "https://medicalbuyer.co.in/biomerica-secures-usd-1-75m-contract-for-ivd-diagnostic-development/", "source_name": "Medical Buyer", "published_at": "2026-05-30T05:39:17", "published_display": "30 May 2026 05:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc. Awarded $1.75 Million Contract for IVD Product Development", "summary": "Biomerica Inc. has secured a $1.75 million contract under a Master Services Agreement for the development of in vitro diagnostic (IVD) products. Operating as a contract development and manufacturing organization (CDMO), Biomerica will provide comprehensive services including prod", "url": "https://www.geneonline.com/biomerica-inc-awarded-1-75-million-contract-for-ivd-product-development/", "source_name": "www.geneonline.com", "published_at": "2026-05-29T07:40:50", "published_display": "29 May 2026 07:40", "sentiment": "positive", "sentiment_pct": 82, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development", "summary": "Biomerica, Inc. announced it has secured a Master Services Agreement with a confidential life sciences company for over $1.75 million to develop proprietary in vitro diagnostic (IVD) assays. This agreement leverages Biomerica's existing ELISA-based assay development expertise and", "url": "https://www.manilatimes.net/2026/05/28/tmt-newswire/globenewswire/biomerica-lands-a-175-million-cdmo-master-services-agreement-for-ivd-diagnostic-development/2353670/amp", "source_name": "The Manila Times", "published_at": "2026-05-29T07:39:17", "published_display": "29 May 2026 07:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica signs contract development deal worth over $1.75M", "summary": "Biomerica, Inc. announced a Master Services Agreement with an undisclosed life sciences company, valued at over $1.75 million, to develop in vitro diagnostic assays. This deal provides significant near-term revenue visibility for Biomerica, which has recently faced a 23.8% revenu", "url": "https://www.investing.com/news/company-news/biomerica-signs-contract-development-deal-worth-over-175m-93CH-4714343", "source_name": "Investing.com", "published_at": "2026-05-28T20:09:35", "published_display": "28 May 2026 20:09", "sentiment": "positive", "sentiment_pct": 67, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica signs contract development deal worth over $1.75M By Investing.com", "summary": "Biomerica, Inc. has secured a Master Services Agreement worth over $1.75 million with an undisclosed life sciences company to develop in vitro diagnostic assays. This deal provides near-term revenue visibility for Biomerica, which has been facing revenue challenges, but also come", "url": "https://ng.investing.com/news/stock-market-news/biomerica-signs-contract-development-deal-worth-over-175m-93CH-2533230", "source_name": "Investing.com Nigeria", "published_at": "2026-05-28T19:09:59", "published_display": "28 May 2026 19:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Wins $1.75M Contract to Develop Diagnostic Tests", "summary": "Biomerica Inc. has secured a $1.75 million master services agreement with an undisclosed life sciences company to develop in vitro diagnostic assays. The three-year contract involves all development work being performed at Biomerica\u2019s Irvine facility. This agreement provides near", "url": "https://www.ocbj.com/healthcare/biomerica-wins-1-75m-contract-to-develop-diagnostic-tests/", "source_name": "Orange County Business Journal", "published_at": "2026-05-28T17:40:23", "published_display": "28 May 2026 17:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica (BMRA) Secures Master Services Agreement for Diagnostic Development", "summary": "Biomerica Inc. (BMRA) has announced a significant master services agreement with a private life sciences firm for the development of specialized in vitro diagnostic assays, including an initial contract target fee exceeding $1.75 million. Despite this new partnership, the company", "url": "https://www.gurufocus.com/news/8889063/biomerica-bmra-secures-master-services-agreement-for-diagnostic-development", "source_name": "GuruFocus", "published_at": "2026-05-28T16:40:23", "published_display": "28 May 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Undisclosed $1.75M lab deal taps Biomerica\u2019s diagnostic test expertise", "summary": "Biomerica (Nasdaq: BMRA) has secured a three-year, auto-renewing CDMO Master Services Agreement with a confidential life sciences partner to develop proprietary IVD assays. This agreement targets over $1.75 million in initial development fees and will leverage Biomerica's existin", "url": "https://www.stocktitan.net/news/BMRA/biomerica-lands-a-1-75-million-cdmo-master-services-agreement-for-qb7m6z9054yj.html", "source_name": "Stock Titan", "published_at": "2026-05-28T12:40:23", "published_display": "28 May 2026 12:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Q1 2026 Earnings: Net Loss of $0.44 Per Share Amid Lack of Revenue Disclosure - Dividend Cut Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNSGw0TFJhYmhRaU5IVFdFdGxGcVZzRUdiMjRjbk1RU0N2cGlqcmxLMDBRRjhwQmtWOVo4OTdpZnhFMnJIWWl1QUNyeW4wd3N3eXRhQV9YLXR5UUFYN0NodW81SDhOcW9OcFpRQkpONG4tcERtWXg3cFc4MzlfTjZXcXpPVUxfajRldGQ0bWcyajlFcDBOajRlUVluUGYwQUU4VUZxbEhYZ0lUYjlVZ3oyRF9fWUNyVjBybW9adVZOdkRzTnNHZDFDc1BCQQ?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 5, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc. (BMRA) Q1 2026 Earnings: Negative EPS Persists Amid Pre-Revenue Stage - Share Dilution Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPRnRJekVHclIybi1vbXN2RVp4aEptVFl3S1FKajBOanB3MndBTzBRNVJjTnpkbDd5MHY5Ulo2WmZCNG5wdnlWcmFDbEZ3Y2VqSmc1YThGeEVzb2hXdzlFTzRvdzZEdGRqNXIyV203Y3ZrUXpSMnFVS2NjYm9GdlBKY3RKUkZkeFhNTE1pX0hVTVpPdU1GbDNLRFliQXgxTkdsQUJfMERpTm94azgwX0hPUmxnU2ZHU09jaTFmSjRGTV92ZDN6?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BMRA Q1 2026 Earnings: Biomerica Reports Net Loss of $0.44 Per Share Amid Ongoing Development Efforts - Earnings Beat Streak", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxOem5Qd0NSOWF3M1RrdTZmQXZCaDFVZ1gtT2xiVm1ON1gwRTZ4Tm03YnZickNKeGFQY0tOYnhwTE9SZDJTcUZJLXI1dVY2LXdqSFVYemxHUG9Xakh1Sm84aU5BYm5lTWlIRXNqUkNRcVcycWRkdTk1eWNKbFc5X28xMFBuQlhPcG5sYkFTX2VSamo3YU9yNlQ4cGoxekNUcElUWTNtbFh2MUxUNEVFUFBvMkdwSzRZX0haSEhGZjlfQlVXUzZfM2Q0elhMS2ZiLTdtV1I2SEVR?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "ConsumerDirect names Gary Lu as chief financial officer", "summary": "ConsumerDirect Inc. has appointed Gary Lu as its new Chief Financial Officer. Lu, previously CFO at Biomerica Inc., will oversee all financial operations, cash management, forecasting, and regulatory compliance for ConsumerDirect. His background includes extensive experience in f", "url": "https://m.uk.investing.com/news/stock-market-news/consumerdirect-names-gary-lu-as-chief-financial-officer-93CH-4687871?ampMode=1", "source_name": "Investing.com UK", "published_at": "2026-05-19T19:38:44", "published_display": "19 May 2026 19:38", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ConsumerDirect names Gary Lu as chief financial officer By Investing.com", "summary": "ConsumerDirect Inc. has appointed Gary Lu as its new Chief Financial Officer. Lu, who previously served as CFO of Biomerica Inc., will manage ConsumerDirect's financial operations, including cash and revenue management, forecasting, and regulatory compliance. His extensive experi", "url": "https://m.za.investing.com/news/stock-market-news/consumerdirect-names-gary-lu-as-chief-financial-officer-93CH-4289662?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-05-19T15:09:58", "published_display": "19 May 2026 15:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ConsumerDirect adds new CFO to scale its subscription business", "summary": "ConsumerDirect Inc. has appointed Gary Lu, CPA, as its new Chief Financial Officer. Lu brings over two decades of financial and operational leadership experience from public companies and high-growth organizations, including his recent role as CFO of Biomerica, Inc. He will be re", "url": "https://www.stocktitan.net/news/BMRA/consumer-direct-expands-executive-team-with-appointment-of-gary-lu-9jasjet22r0v.html", "source_name": "Stock Titan", "published_at": "2026-05-19T13:09:26", "published_display": "19 May 2026 13:09", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica\u2019s inFoods\u00ae IBS Data Accepted for Presentation at Digestive Disease Week 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/biomerica-infoods-ibs-data-accepted-121900593.html", "source_name": "GlobeNewswire", "published_at": "2026-04-29T12:19:00+00:00", "published_display": "29 Apr 2026 12:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biomerica, Inc. Receives Medicare Confirmation for inFoods\u00ae IBS Claims Processing Pathway", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPRXI1c2Z1TERYQnBabnlmMVF2S2xRLVJweFVhb1MtOXZJc2tqaDJCOXFHRkRDNnFZek9lSVlrdnlwWXlEeGIybl9oVjU5bFlYUUJTei1QTW1sRTJmRmdiTnZFeXNieGd1cUZTWWZpV29yN3lFUFJMS21xRlp1R1p4d2l2WmZ5V09RX3pINmxFRko5TzJuZnpzR3BJcmJ2R2NYZ09YQjk1VDY0bzBGcXJxeWNKZnl0eWQzdGVscGsxaWVXNVRuRk4xTQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biomerica Reports Real-World Data Showing 49% Reduction in IBS S", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAJBVV95cUxQMVNTQUhyRW1FSGNlX3I3MUxKMzZudG05b1RUY0oyemZkZDVvQ1FseUtDemMzeG0yNWZOY0htN2tZNzBNWjRBM1lzME9OUGc1LVpCU0tjbFlURFVEUzM0RGRnU2llbzhPbktHYWdjNXpJdHhrS3NwY29FVnpvQmdOcllCVXl4N0JrSVFhaTUzeG5uWDA1MTdjQWJmN3VNZG9kbzRmWEFTeGRPeVNoYmNxWEVMZE9tYkdSV3ZHTnBkam5iX05vdmsyS2RWRDZHcllENUc4d09mNFduQUpMYUk0ZjlFblJLU1hTb1BsLTktOGlJc0JMM0luRUNPbzdlT0hOZkJKX29wUlQxS2UyWU15SUlwYjV2UWtiZWJVQTBVMGlSZjhPLWEtb2dxV2RSZnNYUlVhUmlYM2NxcmRh?oc=5", "source_name": "GuruFocus", "published_at": "2025-05-22T07:00:00+00:00", "published_display": "22 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica (BMRA) Announces 1-for-8 Reverse Stock Split Effective", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPSjlwSy1XWmUta19KVHV6eEZFZWMtTEtNdzQwaFBGVDdQQ05mekg3blBrX1RrN3JWTm5CR2t2MEs4Q1o3Ri1FSDgzTmZDY3JFRHh4c0w3ckxiRHZUNTVMQndkRVFxRVRwQXMxS1lyMDR1bnM2ZzVfRTNYaGQyRkZzbVM1ZTU0QmdFUVNQWnBVdW42MFFaUWpkb0k4N19jWTBDSnQwc19ncUsycnhCczBqOTFZQWZ1d2lFcFpFYnFMMnAxUG1ITXpjZUdTckNNSEdOWk1UbHpXTnEzY2V1QnZGSUZ4VVM?oc=5", "source_name": "GuruFocus", "published_at": "2025-04-16T07:00:00+00:00", "published_display": "16 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica (BMRA) Earnings Report Date & History", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE5FV3VORjZqZkxqT3kyejhZYVZ2NXFDOGpTT2xUNjc4RFhUTFJnMGw4NHB2ZHo5dVM0TmJRSFdDYzBBUWlLNFY4aGpWRTRicmwxajZIZg?oc=5", "source_name": "CoinCodex", "published_at": "2023-08-09T08:35:46+00:00", "published_display": "09 Aug 2023 08:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica (BMRA) Stock Forecast & Price Prediction 2026\u20132030", "summary": "", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE5KajZmd2xVN0tZclhuZEE2V3NwaW0td3d4Njh4VmdlRkhmdUpTd2hFOEd5TEtDRmhEUm43bzlwa0FLdU1BWkdaQ2hyMjBtYWFvRktaSWtlVUxOemwzNnE4?oc=5", "source_name": "CoinCodex", "published_at": "2021-03-15T13:47:42+00:00", "published_display": "15 Mar 2021 13:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Stock Price Forecast. Should You Buy BMRA?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTE5RU1J3a2hrWWtKYzh4RUZQbTNYUUxGeHVEYk9HZVpMTmhZMzFlN3Zzekdhb3ZsZ0JLVW1Eb2MwS01sN0tSLVhDTw?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-01T11:36:58+00:00", "published_display": "01 Dec 2020 11:36", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica (BMRA) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE4wOEsyMnkxSm5iWnc1TUFWSkl4UnBMYWo3MHNLMXZVMXRxb2RxUjhqX0dxRzFYOXo4cXRURWs2N1J5Q29tVGhBNC1ISWZPZzFXdl9DTDZsTF8zdw?oc=5", "source_name": "MarketBeat", "published_at": "2017-11-15T04:08:53+00:00", "published_display": "15 Nov 2017 04:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BMRA Stock Price and Chart \u2014 NASDAQ:BMRA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE5tRWlXcGxIaW1NZDFZNU5yT2RjR2NZczBqVGJQZXBKYjJIZlJkT0Z5eDA2TFBlQTMwMUFGektxX1VuaFFId3lBLTdfNV9lTExSb1lwOVRwbXo2SHVw?oc=5", "source_name": "TradingView", "published_at": "2017-07-31T07:15:23+00:00", "published_display": "31 Jul 2017 07:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "BMRA - Biomerica Inc Short Interest", "summary": "This article provides a detailed financial overview and short interest data for Biomerica Inc. (BMRA). It includes key metrics such as market capitalization, sales, earnings per share, profit margins, and various performance indicators. The data also highlights the short interest", "url": "https://finviz.com/stock?t=BMRA&ty=si&p=d", "source_name": "Finviz", "published_at": "2026-07-06T00:10:55", "published_display": "06 Jul 2026 00:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BMRA - Biomerica Inc Earnings", "summary": "This page provides an overview of Biomerica Inc.'s (BMRA) financial performance and key metrics. It includes details such as market capitalization, sales, income, EPS, insider ownership, institutional ownership, profitability ratios, and stock performance data. The company's stoc", "url": "https://finviz.com/stock?t=BMRA&ty=ea&p=d", "source_name": "Finviz", "published_at": "2026-07-04T23:39:50", "published_display": "04 Jul 2026 23:39", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Biomerica, Inc. \u2013 NASDAQ:BMRA", "summary": "The article focuses on the enterprise value to EBITDA forward for Biomerica, Inc. (NASDAQ: BMRA). It appears to be a financial data page from TradingView, displaying stock information and financial metrics for the company. The content also mentions the data sources and copyright ", "url": "https://www.tradingview.com/symbols/NASDAQ-BMRA/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T13:40:04", "published_display": "28 Jun 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Biomerica, Inc. \u2013 NASDAQ:BMRA", "summary": "This article provides financial data for Biomerica, Inc. (NASDAQ: BMRA), focusing on its forward price-to-sales ratio. It indicates that the market was closed with no trades at the time of reporting. The content is primarily a data page from TradingView, offering financial and ma", "url": "https://www.tradingview.com/symbols/NASDAQ-BMRA/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T09:11:26", "published_display": "26 Jun 2026 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc (BMRA) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis of Biomerica Inc (BMRA), stating its current valuation score is 7.63, ranking 142 out of 203 in its industry. It highlights the company's current P/E ratio at -1.08, noting it is significantly below its recent high and above its recent l", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bmra/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-24T19:11:26", "published_display": "24 Jun 2026 19:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc (BMRA) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Biomerica Inc (BMRA) currently has a financial score of 6.12, ranking 174 out of 204 in the Healthcare Equipment & Supplies industry, indicating robust financial status but low operating efficiency. Its latest quarterly revenue saw an 11.80% year-over-year decrease to $987.00K, a", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bmra/financial-health", "source_name": "TradingKey", "published_at": "2026-06-23T07:11:43", "published_display": "23 Jun 2026 07:11", "sentiment": "negative", "sentiment_pct": 37, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans - moomoo", "summary": "This article states that Biomerica has filed an S-8 initial registration statement. This statement is for securities intended to be offered to employees through employee benefit plans. The filing was made public via moomoo.", "url": "https://www.moomoo.com/news/notice/306568807/biomerica-s-8-initial-registration-statement-for-securities-to-be", "source_name": "Moomoo", "published_at": "2026-06-22T07:40:00", "published_display": "22 Jun 2026 07:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc (BMRA) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "The article provides an earnings forecast for Biomerica Inc (BMRA), noting that no earnings forecast score is currently available for the company. It indicates that the Healthcare Equipment & Supplies industry average score is 7.78. The page also displays current stock informatio", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bmra/earnings", "source_name": "TradingKey", "published_at": "2026-06-19T07:38:54", "published_display": "19 Jun 2026 07:38", "sentiment": "negative", "sentiment_pct": 41, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc (BMRA) Institutional Confidence", "summary": "This article from TradingKey focuses on the institutional confidence score for Biomerica Inc (BMRA), which stands at 3.00, unchanged as of June 18, 2026. It details the shareholdings and activity of several key individual and institutional shareholders, highlighting changes in th", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bmra/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T16:40:31", "published_display": "18 Jun 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc (BMRA) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Biomerica Inc.'s (BMRA) dividend history and stock split events. It indicates that the company has distributed no dividends in the past five years and notes a merger-type stock split event scheduled for April 16, 2025, with an 8-for-1 ratio. T", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bmra/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T16:38:54", "published_display": "17 Jun 2026 16:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc (BMRA) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Biomerica Inc (BMRA), detailing its current price momentum score as 4.88, trading between a resistance level of $2.34 and a support level of $1.75. The analysis includes various technical indicators like MACD, RSI, and moving averages", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bmra/technical", "source_name": "TradingKey", "published_at": "2026-06-17T16:11:18", "published_display": "17 Jun 2026 16:11", "sentiment": "negative", "sentiment_pct": 12, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc (BMRA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for Biomerica Inc (BMRA), categorizing its revenue by business segment and geographical region. As of FY2026Q2, Clinical Lab and OTC segments are the largest contributors, while the United States and Asia lead in regional revenue", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bmra/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T15:40:19", "published_display": "17 Jun 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc (BMRA) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Biomerica Inc (BMRA), outlining both individual major shareholders and institutional holdings. It provides a breakdown of proportional ownership for key individuals like Zackary S. Irani, Allen Barbieri, and Gary Lu, as well as sh", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bmra/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T15:40:19", "published_display": "17 Jun 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica (BMRA) Q1 2026 Earnings: Narrowing Loss Amid Ongoing Operational Challenges - Negative Surprise Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQY1pnWi1oMXFlRTBCeC0zY0pmMy1QY1V1Qjl5MXcxQ3FSSnV4S2NxZEVkMXpmTkpGREExSmU5ZUM4NVB3U05Balk5ZHFuUkRGSXllUndtNjgxM3VYV1dOM3NDR0RfSFBPYmtsbUhVNFhsUldhRVJZWTJCSkhDNHpJTUtZUU9XS0phTmVycS14ZlZxM2RQTWFlT1hlMVJ2YUtxNDM2NFZMQUk2Nkh5Y2RfRHdqQnE3YWNLSVJoMlpYVDZiLVhLdExPSnRSaEY?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica to Sell 6% Diagnosis Stake for $500,000; Issues 8% Note Pending Transfer", "summary": "Biomerica has agreed to sell a 6% stake in Diagnosis for $500,000 to affiliates of CEO Zackary Irani. Pending Polish approvals, Biomerica issued a secured 12-month note at 8% to hold the funds, which will be forgiven upon closing, except for 60 days of interest. The transaction i", "url": "https://www.tradingview.com/news/tradingview:3197901bbd14e:0-biomerica-to-sell-6-diagnosis-stake-for-500-000-issues-8-note-pending-transfer/", "source_name": "TradingView", "published_at": "2026-06-04T21:10:19", "published_display": "04 Jun 2026 21:10", "sentiment": "positive", "sentiment_pct": 63, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica (BMRA) sells 6% Diagnosis S.A. stake to CEO-affiliated buyers", "summary": "Biomerica, Inc. has entered into an agreement to sell 78,750 shares of Diagnosis S.A., roughly 6% of its outstanding shares, to buyers affiliated with its CEO, Zackary Irani, for $500,000. The transaction involves a secured promissory term note bearing 8% annual interest, maturin", "url": "https://www.stocktitan.net/sec-filings/BMRA/8-k-biomerica-inc-reports-material-event-2a02a17fb1d7.html", "source_name": "Stock Titan", "published_at": "2026-06-04T21:10:19", "published_display": "04 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BMRA - Biomerica Inc Stock Price and Quote", "summary": "This article provides a detailed financial overview and recent news for Biomerica Inc. (BMRA), including its stock price, market capitalization, key financial ratios, and performance metrics. It also lists recent company announcements, such as new product approvals, clinical stud", "url": "https://finviz.com/stock?t=BMRA", "source_name": "Finviz", "published_at": "2026-05-30T21:40:06", "published_display": "30 May 2026 21:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica secures USD 1.75M contract for IVD diagnostic development", "summary": "Biomerica, Inc. has secured a Master Services Agreement with a confidential life sciences company for over $1.75 million to develop proprietary in vitro diagnostic (IVD) assays. This CDMO engagement leverages Biomerica's existing ELISA-based assay development expertise and infras", "url": "https://medicalbuyer.co.in/biomerica-secures-usd-1-75m-contract-for-ivd-diagnostic-development/", "source_name": "Medical Buyer", "published_at": "2026-05-30T05:39:17", "published_display": "30 May 2026 05:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc. Awarded $1.75 Million Contract for IVD Product Development", "summary": "Biomerica Inc. has secured a $1.75 million contract under a Master Services Agreement for the development of in vitro diagnostic (IVD) products. Operating as a contract development and manufacturing organization (CDMO), Biomerica will provide comprehensive services including prod", "url": "https://www.geneonline.com/biomerica-inc-awarded-1-75-million-contract-for-ivd-product-development/", "source_name": "www.geneonline.com", "published_at": "2026-05-29T07:40:50", "published_display": "29 May 2026 07:40", "sentiment": "positive", "sentiment_pct": 82, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development", "summary": "Biomerica, Inc. announced it has secured a Master Services Agreement with a confidential life sciences company for over $1.75 million to develop proprietary in vitro diagnostic (IVD) assays. This agreement leverages Biomerica's existing ELISA-based assay development expertise and", "url": "https://www.manilatimes.net/2026/05/28/tmt-newswire/globenewswire/biomerica-lands-a-175-million-cdmo-master-services-agreement-for-ivd-diagnostic-development/2353670/amp", "source_name": "The Manila Times", "published_at": "2026-05-29T07:39:17", "published_display": "29 May 2026 07:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica signs contract development deal worth over $1.75M", "summary": "Biomerica, Inc. announced a Master Services Agreement with an undisclosed life sciences company, valued at over $1.75 million, to develop in vitro diagnostic assays. This deal provides significant near-term revenue visibility for Biomerica, which has recently faced a 23.8% revenu", "url": "https://www.investing.com/news/company-news/biomerica-signs-contract-development-deal-worth-over-175m-93CH-4714343", "source_name": "Investing.com", "published_at": "2026-05-28T20:09:35", "published_display": "28 May 2026 20:09", "sentiment": "positive", "sentiment_pct": 67, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica signs contract development deal worth over $1.75M By Investing.com", "summary": "Biomerica, Inc. has secured a Master Services Agreement worth over $1.75 million with an undisclosed life sciences company to develop in vitro diagnostic assays. This deal provides near-term revenue visibility for Biomerica, which has been facing revenue challenges, but also come", "url": "https://ng.investing.com/news/stock-market-news/biomerica-signs-contract-development-deal-worth-over-175m-93CH-2533230", "source_name": "Investing.com Nigeria", "published_at": "2026-05-28T19:09:59", "published_display": "28 May 2026 19:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Wins $1.75M Contract to Develop Diagnostic Tests", "summary": "Biomerica Inc. has secured a $1.75 million master services agreement with an undisclosed life sciences company to develop in vitro diagnostic assays. The three-year contract involves all development work being performed at Biomerica\u2019s Irvine facility. This agreement provides near", "url": "https://www.ocbj.com/healthcare/biomerica-wins-1-75m-contract-to-develop-diagnostic-tests/", "source_name": "Orange County Business Journal", "published_at": "2026-05-28T17:40:23", "published_display": "28 May 2026 17:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica (BMRA) Secures Master Services Agreement for Diagnostic Development", "summary": "Biomerica Inc. (BMRA) has announced a significant master services agreement with a private life sciences firm for the development of specialized in vitro diagnostic assays, including an initial contract target fee exceeding $1.75 million. Despite this new partnership, the company", "url": "https://www.gurufocus.com/news/8889063/biomerica-bmra-secures-master-services-agreement-for-diagnostic-development", "source_name": "GuruFocus", "published_at": "2026-05-28T16:40:23", "published_display": "28 May 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Undisclosed $1.75M lab deal taps Biomerica\u2019s diagnostic test expertise", "summary": "Biomerica (Nasdaq: BMRA) has secured a three-year, auto-renewing CDMO Master Services Agreement with a confidential life sciences partner to develop proprietary IVD assays. This agreement targets over $1.75 million in initial development fees and will leverage Biomerica's existin", "url": "https://www.stocktitan.net/news/BMRA/biomerica-lands-a-1-75-million-cdmo-master-services-agreement-for-qb7m6z9054yj.html", "source_name": "Stock Titan", "published_at": "2026-05-28T12:40:23", "published_display": "28 May 2026 12:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Q1 2026 Earnings: Net Loss of $0.44 Per Share Amid Lack of Revenue Disclosure - Dividend Cut Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNSGw0TFJhYmhRaU5IVFdFdGxGcVZzRUdiMjRjbk1RU0N2cGlqcmxLMDBRRjhwQmtWOVo4OTdpZnhFMnJIWWl1QUNyeW4wd3N3eXRhQV9YLXR5UUFYN0NodW81SDhOcW9OcFpRQkpONG4tcERtWXg3cFc4MzlfTjZXcXpPVUxfajRldGQ0bWcyajlFcDBOajRlUVluUGYwQUU4VUZxbEhYZ0lUYjlVZ3oyRF9fWUNyVjBybW9adVZOdkRzTnNHZDFDc1BCQQ?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 5, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Inc. (BMRA) Q1 2026 Earnings: Negative EPS Persists Amid Pre-Revenue Stage - Share Dilution Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPRnRJekVHclIybi1vbXN2RVp4aEptVFl3S1FKajBOanB3MndBTzBRNVJjTnpkbDd5MHY5Ulo2WmZCNG5wdnlWcmFDbEZ3Y2VqSmc1YThGeEVzb2hXdzlFTzRvdzZEdGRqNXIyV203Y3ZrUXpSMnFVS2NjYm9GdlBKY3RKUkZkeFhNTE1pX0hVTVpPdU1GbDNLRFliQXgxTkdsQUJfMERpTm94azgwX0hPUmxnU2ZHU09jaTFmSjRGTV92ZDN6?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BMRA Q1 2026 Earnings: Biomerica Reports Net Loss of $0.44 Per Share Amid Ongoing Development Efforts - Earnings Beat Streak", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxOem5Qd0NSOWF3M1RrdTZmQXZCaDFVZ1gtT2xiVm1ON1gwRTZ4Tm03YnZickNKeGFQY0tOYnhwTE9SZDJTcUZJLXI1dVY2LXdqSFVYemxHUG9Xakh1Sm84aU5BYm5lTWlIRXNqUkNRcVcycWRkdTk1eWNKbFc5X28xMFBuQlhPcG5sYkFTX2VSamo3YU9yNlQ4cGoxekNUcElUWTNtbFh2MUxUNEVFUFBvMkdwSzRZX0haSEhGZjlfQlVXUzZfM2Q0elhMS2ZiLTdtV1I2SEVR?oc=5", "source_name": "dars.gov.et", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ConsumerDirect names Gary Lu as chief financial officer", "summary": "ConsumerDirect Inc. has appointed Gary Lu as its new Chief Financial Officer. Lu, previously CFO at Biomerica Inc., will oversee all financial operations, cash management, forecasting, and regulatory compliance for ConsumerDirect. His background includes extensive experience in f", "url": "https://m.uk.investing.com/news/stock-market-news/consumerdirect-names-gary-lu-as-chief-financial-officer-93CH-4687871?ampMode=1", "source_name": "Investing.com UK", "published_at": "2026-05-19T19:38:44", "published_display": "19 May 2026 19:38", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ConsumerDirect names Gary Lu as chief financial officer By Investing.com", "summary": "ConsumerDirect Inc. has appointed Gary Lu as its new Chief Financial Officer. Lu, who previously served as CFO of Biomerica Inc., will manage ConsumerDirect's financial operations, including cash and revenue management, forecasting, and regulatory compliance. His extensive experi", "url": "https://m.za.investing.com/news/stock-market-news/consumerdirect-names-gary-lu-as-chief-financial-officer-93CH-4289662?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-05-19T15:09:58", "published_display": "19 May 2026 15:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ConsumerDirect adds new CFO to scale its subscription business", "summary": "ConsumerDirect Inc. has appointed Gary Lu, CPA, as its new Chief Financial Officer. Lu brings over two decades of financial and operational leadership experience from public companies and high-growth organizations, including his recent role as CFO of Biomerica, Inc. He will be re", "url": "https://www.stocktitan.net/news/BMRA/consumer-direct-expands-executive-team-with-appointment-of-gary-lu-9jasjet22r0v.html", "source_name": "Stock Titan", "published_at": "2026-05-19T13:09:26", "published_display": "19 May 2026 13:09", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica\u2019s inFoods\u00ae IBS Data Accepted for Presentation at Digestive Disease Week 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/biomerica-infoods-ibs-data-accepted-121900593.html", "source_name": "GlobeNewswire", "published_at": "2026-04-29T12:19:00+00:00", "published_display": "29 Apr 2026 12:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica, Inc. Receives Medicare Confirmation for inFoods\u00ae IBS Claims Processing Pathway", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPRXI1c2Z1TERYQnBabnlmMVF2S2xRLVJweFVhb1MtOXZJc2tqaDJCOXFHRkRDNnFZek9lSVlrdnlwWXlEeGIybl9oVjU5bFlYUUJTei1QTW1sRTJmRmdiTnZFeXNieGd1cUZTWWZpV29yN3lFUFJMS21xRlp1R1p4d2l2WmZ5V09RX3pINmxFRko5TzJuZnpzR3BJcmJ2R2NYZ09YQjk1VDY0bzBGcXJxeWNKZnl0eWQzdGVscGsxaWVXNVRuRk4xTQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Reports Real-World Data Showing 49% Reduction in IBS S", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAJBVV95cUxQMVNTQUhyRW1FSGNlX3I3MUxKMzZudG05b1RUY0oyemZkZDVvQ1FseUtDemMzeG0yNWZOY0htN2tZNzBNWjRBM1lzME9OUGc1LVpCU0tjbFlURFVEUzM0RGRnU2llbzhPbktHYWdjNXpJdHhrS3NwY29FVnpvQmdOcllCVXl4N0JrSVFhaTUzeG5uWDA1MTdjQWJmN3VNZG9kbzRmWEFTeGRPeVNoYmNxWEVMZE9tYkdSV3ZHTnBkam5iX05vdmsyS2RWRDZHcllENUc4d09mNFduQUpMYUk0ZjlFblJLU1hTb1BsLTktOGlJc0JMM0luRUNPbzdlT0hOZkJKX29wUlQxS2UyWU15SUlwYjV2UWtiZWJVQTBVMGlSZjhPLWEtb2dxV2RSZnNYUlVhUmlYM2NxcmRh?oc=5", "source_name": "GuruFocus", "published_at": "2025-05-22T07:00:00+00:00", "published_display": "22 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica (BMRA) Announces 1-for-8 Reverse Stock Split Effective", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxPSjlwSy1XWmUta19KVHV6eEZFZWMtTEtNdzQwaFBGVDdQQ05mekg3blBrX1RrN3JWTm5CR2t2MEs4Q1o3Ri1FSDgzTmZDY3JFRHh4c0w3ckxiRHZUNTVMQndkRVFxRVRwQXMxS1lyMDR1bnM2ZzVfRTNYaGQyRkZzbVM1ZTU0QmdFUVNQWnBVdW42MFFaUWpkb0k4N19jWTBDSnQwc19ncUsycnhCczBqOTFZQWZ1d2lFcFpFYnFMMnAxUG1ITXpjZUdTckNNSEdOWk1UbHpXTnEzY2V1QnZGSUZ4VVM?oc=5", "source_name": "GuruFocus", "published_at": "2025-04-16T07:00:00+00:00", "published_display": "16 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica (BMRA) Earnings Report Date & History", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE5FV3VORjZqZkxqT3kyejhZYVZ2NXFDOGpTT2xUNjc4RFhUTFJnMGw4NHB2ZHo5dVM0TmJRSFdDYzBBUWlLNFY4aGpWRTRicmwxajZIZg?oc=5", "source_name": "CoinCodex", "published_at": "2023-08-09T08:35:46+00:00", "published_display": "09 Aug 2023 08:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica (BMRA) Stock Forecast & Price Prediction 2026\u20132030", "summary": "", "url": "https://news.google.com/rss/articles/CBMiX0FVX3lxTE5KajZmd2xVN0tZclhuZEE2V3NwaW0td3d4Njh4VmdlRkhmdUpTd2hFOEd5TEtDRmhEUm43bzlwa0FLdU1BWkdaQ2hyMjBtYWFvRktaSWtlVUxOemwzNnE4?oc=5", "source_name": "CoinCodex", "published_at": "2021-03-15T13:47:42+00:00", "published_display": "15 Mar 2021 13:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica Stock Price Forecast. Should You Buy BMRA?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTE5RU1J3a2hrWWtKYzh4RUZQbTNYUUxGeHVEYk9HZVpMTmhZMzFlN3Zzekdhb3ZsZ0JLVW1Eb2MwS01sN0tSLVhDTw?oc=5", "source_name": "StockInvest.us", "published_at": "2020-12-01T11:36:58+00:00", "published_display": "01 Dec 2020 11:36", "sentiment": "positive", "sentiment_pct": 66, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biomerica (BMRA) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE4wOEsyMnkxSm5iWnc1TUFWSkl4UnBMYWo3MHNLMXZVMXRxb2RxUjhqX0dxRzFYOXo4cXRURWs2N1J5Q29tVGhBNC1ISWZPZzFXdl9DTDZsTF8zdw?oc=5", "source_name": "MarketBeat", "published_at": "2017-11-15T04:08:53+00:00", "published_display": "15 Nov 2017 04:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BMRA Stock Price and Chart \u2014 NASDAQ:BMRA", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXEFVX3lxTE5tRWlXcGxIaW1NZDFZNU5yT2RjR2NZczBqVGJQZXBKYjJIZlJkT0Z5eDA2TFBlQTMwMUFGektxX1VuaFFId3lBLTdfNV9lTExSb1lwOVRwbXo2SHVw?oc=5", "source_name": "TradingView", "published_at": "2017-07-31T07:15:23+00:00", "published_display": "31 Jul 2017 07:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 87, "total_relevant": 51, "sentiment_summary": {"positive": 11, "negative": 8, "neutral": 32, "score": 52, "total": 51, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 74, "events": [{"event": "earnings", "label": "Earnings", "weight": 10.59, "count": 22}, {"event": "general", "label": "Market update", "weight": 8.8, "count": 16}, {"event": "deals", "label": "Deals and strategy", "weight": 5.5, "count": 10}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 11, "negative_events": 8}, "market_context": {"has_market_context": true, "latest_close": 1.69, "latest_week": "2026-07-10", "one_week_move": -3.4, "four_week_move": -17.6, "twelve_week_move": -22.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.726499, "market_dynamics_buy_signal": false, "relative_strength": -42.560178, "fair_value_gap": -61.8, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 40.5773, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.4% over one week, -17.6% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 58, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 9}, {"label": "TradingKey", "count": 8}, {"label": "TradingView", "count": 4}, {"label": "Finviz", "count": 3}, {"label": "Donan\u0131mHaber", "count": 3}, {"label": "Stock Titan", "count": 3}, {"label": "GuruFocus", "count": 3}, {"label": "StockStory", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 40}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 22}, {"label": "Market update", "count": 16}, {"label": "Deals and strategy", "count": 10}, {"label": "Guidance", "count": 2}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "74/100 classification confidence."}, {"label": "Company focus", "value": "40", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.4% over one week, -17.6% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "BMRA - Biomerica Inc Short Interest"}], "updated_at": "2026-07-17T00:25:06.232427+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}